Oncternal Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Quarter Ending	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jun '23 Jun 30, 2023	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022	Jun '22 Jun 30, 2022	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Sep '21 Sep 30, 2021	Jun '21 Jun 30, 2021	Mar '21 Mar 31, 2021	Dec '20 Dec 31, 2020	Sep '20 Sep 30, 2020	Jun '20 Jun 30, 2020	Mar '20 Mar 31, 2020	Dec '19 Dec 31, 2019
Net Income	-8.46	-8.56	-8.39	-9.16	-9.86	-8.97	-11.49	-11.4	-11.13	-11.74	-9.9	-8.07	-9.63	-7.68	-5.95	-2.56	-4.4	-5.54	-4.74	-4.16
Depreciation & Amortization	0.04	0.04	0.03	0.03	0.08	0.04	0.04	0.04	0.04	0.07	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.09
Share-Based Compensation	1.85	1.38	1.36	2.22	1.72	1.68	1.89	1.8	1.97	1.68	1.98	1.71	1.49	1.84	0.84	0.41	0.41	0.34	0.4	0.26
Other Operating Activities	-0.38	1.32	-0.44	0.5	2.56	-2.01	-1.4	0.56	-2.85	2.87	-0.72	-0.3	1.72	-1.8	-0.92	-1.8	-1.38	0.93	0.27	0.76
Operating Cash Flow	-6.95	-5.82	-7.44	-6.42	-5.51	-9.26	-10.97	-9	-11.97	-7.13	-8.61	-6.62	-6.38	-7.61	-5.99	-3.91	-5.33	-4.22	-4.04	-3.05
Change in Investments	13.65	5.81	7.22	-1.81	4.66	13.85	-16.05	-26.5	0	0	0	0	0	0	0	0	0	0	0	0
Investing Cash Flow	13.65	5.81	7.22	-1.81	4.66	13.85	-16.05	-26.5	0	0	0	0	0	0	0	0	0	0	0	0
Share Issuance / Repurchase	0	0	-0.09	-0	-0.05	-0	1.12	2.01	3.69	3.87	0	0	0.1	0.06	0.46	99.39	9.97	4.52	0	0
Debt Issued / Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0
Financing Cash Flow	0	0	-0.09	-0	-0.05	-0	1.12	2.01	3.69	3.87	0	0	0.1	0.06	0.46	99.39	9.97	4.82	0	0
Net Cash Flow	6.7	-0.01	-0.3	-8.23	-0.91	4.59	-25.9	-33.49	-8.27	-3.26	-8.61	-6.62	-6.28	-7.55	-5.53	95.48	4.64	0.6	-4.03	-3.05
Free Cash Flow	-6.95	-5.82	-7.44	-6.42	-5.51	-9.26	-10.97	-9	-11.97	-7.13	-8.61	-6.62	-6.38	-7.61	-5.99	-3.91	-5.33	-4.22	-4.04	-3.05
Free Cash Flow Margin	-1407.49%	-726.84%	-1307.21%	-2161.28%	-3079.89%	-8738.68%	-5403.45%	-5264.33%	-3132.46%	-3732.98%	-1153.62%	-1189.93%	-299.81%	-861.61%	-800.13%	-246.28%	-910.60%	-677.53%	-698.27%	-413.72%
Free Cash Flow Per Share	-2.35	-1.97	-2.51	-2.18	-1.87	-3.15	-3.75	-3.18	-4.42	-2.85	-3.48	-2.68	-2.58	-3.08	-2.44	-3.85	-5.29	-5.20	-5.26	-5.90

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).